BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31505080)

  • 1. The medical impact of hepatitis D virus infection in Uzbekistan.
    Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Ismoilov U; Colombo M; Caviglia GP; Rizzetto M; Musabaev E
    Liver Int; 2019 Nov; 39(11):2077-2081. PubMed ID: 31505080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider.
    Bahcecioglu IH; Aygun C; Gozel N; Poyrazoglu OK; Bulut Y; Yalniz M
    J Viral Hepat; 2011 Jul; 18(7):518-24. PubMed ID: 20546500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.
    Gheorghe L; Csiki IE; Iacob S; Gheorghe C; Trifan A; Grigorescu M; Motoc A; Suceveanu A; Curescu M; Caruntu F; Sporea I; Brisc C; Rogoveanu I; Cerban R; Tugui L; Alexandrescu A
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):413-21. PubMed ID: 26697566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regular screening for hepatitis delta virus among chronic hepatitis B carriers improves the diagnostic of this infection and of subsequent cirrhosis development.
    Weichselbaum L; Njimi H; van den Wijngaert S; Dahma H; Nkuize M; Van Gossum M; Eisendrath P; Mulkay JP; Sersté T
    United European Gastroenterol J; 2024 May; 12(4):516-525. PubMed ID: 38520063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger.
    Cenac A; Pedroso ML; Djibo A; Develoux M; Pichoud C; Lamothe F; Trepo C; Warter A
    Am J Trop Med Hyg; 1995 Apr; 52(4):293-6. PubMed ID: 7537942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection.
    Roggenbach I; Chi X; Lempp FA; Qu B; Walter L; Wu R; Gao X; Schnitzler P; Ding Y; Urban S; Niu J
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
    Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
    J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
    Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
    Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.
    Mohammad Alizadeh AH; Ranjbar M; Tehrani AS; Keramat F; Mamani M; Rezazadeh M; Aini P; Khalilian A; Majlesi A; Hajilooi M
    J Microbiol Immunol Infect; 2010 Dec; 43(6):519-23. PubMed ID: 21195980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
    Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
    PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach.
    Khan AU; Waqar M; Akram M; Zaib M; Wasim M; Ahmad S; Niaz Z; Ali S; Ali H; Idrees M; Bajwa MA
    Virol J; 2011 Sep; 8():420. PubMed ID: 21888671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort.
    Brancaccio G; Nardi A; Madonia S; Fasano M; Verucchi G; Massari M; Maimone S; Contini C; Levantesi F; Alfieri A; Gavrila C; Andreone P; Milella M; Gaeta GB
    Dig Liver Dis; 2019 Mar; 51(3):438-442. PubMed ID: 30314950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation of hepatitis D in Pakistani children.
    Abbas Z; Soomro GB; Hassan SM; Luck NH
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1098-103. PubMed ID: 25089545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple hepatitis virus infections in chronic HBsAg carriers in Naples.
    Sagnelli E; Felaco FM; Filippini P; Scolastico C; Rapicetta M; Stroffolini T; Piccinino F
    Arch Virol; 1997; 142(3):445-51. PubMed ID: 9349290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
    Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
    J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.